Willem Baralt

Willem Baralt was recently appointed as the new Chairman of the Board at Synthace, a leading digital experiment platform for life science R&D.1 Here are some key details about Willem Baralt:

Professional Background

• Appointed Chairman of Synthace in February 20241
• Previously served as Chief Financial Officer at Quanta Dialysis Technologies from 2014 to 20222
• Played a crucial role in leading Quanta Dialysis Technologies through FDA clearance and commercialization1
• Oversaw several funding rounds at Quanta, including securing a $245 million Series D round, the largest private dialysis company raise in history1

Experience and Expertise

• Accomplished Non-Executive Board Director and Chairman1
• Extensive experience in:
  • Driving commercial growth
  • Devising sustainable strategies
  • Fundraising
  • Overseeing M&A activities
  • Fostering teams1

Current Roles

• Serves on the boards of various private healthcare firms and charitable organizations1
• Chairman of the Board at Synthace (since February 2024)2

Notable Achievements

• Guided Flag Telecom through a NASDAQ IPO1
• Facilitated numerous M&A transactions and restructures1

LinkedIn Profile

Willem Baralt's LinkedIn username is wgbhome.3

Willem Baralt's appointment comes at a time when Synthace is experiencing accelerating growth and expanding its offerings. His expertise is expected to help Synthace integrate AI capabilities with its digital experimentation platform, potentially revolutionizing the R&D landscape in the life sciences industry.1